IDx-DR is an FDA-approved artificial intelligence system that autonomously screens for diabetic retinopathy, a common complication of diabetes. It analyzes retinal images and provides an immediate diagnosis without requiring a specialist, making it a valuable tool for early detection and timely intervention. This system is particularly beneficial in primary care settings, improving access to critical eye care for diabetic patients.